Insider buyers were busy on Nov 20, 2020: 40 companies, $35.7 million in open-market purchases all told. The biggest was OLMA (Olema Pharmaceuticals, Inc.), where BIOTECHNOLOGY VALUE FUND II LP led about $21.6 million of buying.
Eight of the buys came from a CEO or CFO. 84 companies had three or more insiders buying in the past 30 days. One buy doesn't make a thesis, but it's a good place to start digging.